IMDX
Insight Molecular Diagnostics
IMDX
IMDX
65 hedge funds and large institutions have $47M invested in Insight Molecular Diagnostics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
57% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 23
64% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 14
Holders
65
Holding in Top 10
2
Calls
$52K
Puts
–
Top Buyers
| 1 | +$31K | |
| 2 | +$23.8K | |
| 3 | +$22K | |
| 4 |
LPL Financial
San Diego,
California
|
+$21.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$15.8K |
Top Sellers
| 1 | -$201K | |
| 2 | -$163K | |
| 3 | -$152K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$144K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$131K |